Detalles de la búsqueda
1.
Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up.
Haematologica
; 2024 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38546689
2.
Overall survival and causes of death in elderly patients with Hodgkin lymphoma: a Norwegian population-based case-control study.
Haematologica
; 2023 Oct 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37881879
3.
Chronic fatigue in long-term survivors of Hodgkin's lymphoma after contemporary risk-adapted treatment.
Acta Oncol
; 62(1): 80-88, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36715320
4.
Total late effect burden in long-term lymphoma survivors after high-dose therapy with autologous stem-cell transplant and its effect on health-related quality of life.
Haematologica
; 107(11): 2698-2707, 2022 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35484681
5.
Prognostic value of combined MTV and ADC derived from baseline FDG PET/MRI in aggressive non-Hodgkins lymphoma.
BMC Cancer
; 22(1): 1117, 2022 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36319985
6.
A comparison of FDG PET/MR and PET/CT for staging, response assessment, and prognostic imaging biomarkers in lymphoma.
Ann Hematol
; 101(5): 1077-1088, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35174405
7.
Post-treatment work patterns amongst survivors of lymphoma treated with high-dose chemotherapy with autologous stem-cell transplantation.
BMC Cancer
; 21(1): 143, 2021 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33557789
8.
Chemotherapy-induced peripheral neuropathy after modern treatment of Hodgkin's lymphoma; symptom burden and quality of life.
Acta Oncol
; 60(7): 911-920, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33905285
9.
Using blood calprotectin as a measure of blood neutrophils.
Scand J Clin Lab Invest
; 81(4): 303-306, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33787440
10.
Lifestyle behavior among lymphoma survivors after high-dose therapy with autologous hematopoietic stem cell transplantation, assessed by patient-reported outcomes.
Acta Oncol
; 58(5): 690-699, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30696346
11.
Survivors' knowledge of their diagnosis, treatment and possible late adverse effects after autologous stem cell transplantation for lymphoma.
Acta Oncol
; 58(9): 1315-1322, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31286808
12.
Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years.
Biol Blood Marrow Transplant
; 23(3): 428-435, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28039078
13.
A national study on conditional survival, excess mortality and second cancer after high dose therapy with autologous stem cell transplantation for non-Hodgkin lymphoma.
Br J Haematol
; 173(3): 432-43, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26914167
14.
Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma.
Blood
; 123(19): 2953-9, 2014 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-24652994
15.
Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by the Nordic Lymphoma Group.
Haematologica
; 100(4): 534-40, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25480497
16.
PET/MR brain imaging: evaluation of clinical UTE-based attenuation correction.
Eur J Nucl Med Mol Imaging
; 42(9): 1439-46, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25900276
17.
Brentuximab vedotin in relapsed or refractory classical hodgkin lymphoma: real life experience in Norway 2011-2016.
Acta Oncol
; 59(1): 101-105, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31429371
18.
18F-FACBC and 18F-FDG PET/MRI in the evaluation of 3 patients with primary central nervous system lymphoma: a pilot study.
EJNMMI Rep
; 8(1): 2, 2024 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38748286
19.
High-dose therapy with autologous stem cell support for lymphoma in Norway 1987-2008.
Tidsskr Nor Laegeforen
; 133(16): 1704-9, 2013 Sep 03.
Artículo
en Inglés, Nor
| MEDLINE | ID: mdl-24005706
20.
Work ability and work status changes in long-term Hodgkin lymphoma survivors with focus on late adverse effects.
J Cancer Surviv
; 2023 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37526861